← FDA Drug Approvals (Drugs@FDA)

ERIBULIN MESYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: JIANGXI KVVIT PHARM · Approved 2024-06-28

Drug application

FDA Application #

ANDA218281

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERIBULIN MESYLATE

Generic name

ERIBULIN MESYLATE

Active ingredients

ERIBULIN MESYLATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

JIANGXI KVVIT PHARM

Manufacturer

HIKMA PHARMACEUTICALS USA INC.

First approval

2024-06-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown